Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HQY
HQY logo

HQY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
83.930
Open
81.460
VWAP
82.70
Vol
927.79K
Mkt Cap
7.06B
Low
80.600
Amount
76.73M
EV/EBITDA(TTM)
15.59
Total Shares
84.48M
EV
7.52B
EV/OCF(TTM)
16.46
P/S(TTM)
5.42
HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.
Show More

Events Timeline

(ET)
2026-03-17
16:10:00
Company Sees FY27 Revenue of $1.41B to $1.42B
select
2026-03-17
16:10:00
HealthEquity Q4 Revenue $334.6M, Adjusted EBITDA Up 23%
select
2026-03-17
14:10:00
Lululemon and Others Set to Report Earnings, Consensus at $4.78
select

News

Newsfilter
5.0
03-30Newsfilter
HealthEquity Appoints New Board Member to Enhance Governance
  • Board Expansion: HealthEquity announced the election of William Gassen, CEO of Sanford Health, to its board effective March 26, 2026, increasing the board to 10 members, 8 of whom are independent, thereby enhancing corporate governance.
  • Rich Industry Experience: Gassen's leadership experience at Sanford Health will provide HealthEquity with deep insights into healthcare delivery and financing, helping the company better address the challenges faced by consumers, providers, and employers in the healthcare system.
  • Focus on Affordability: Gassen emphasized that affordability in healthcare remains a significant challenge for many families and employers, and HealthEquity plays a crucial role in helping people prepare for healthcare expenses, further solidifying the company's market position.
  • Educational Background and Professional Experience: Gassen holds a bachelor's degree in criminal justice and a J.D. from the University of South Dakota, and has held several senior leadership roles at Sanford Health, bringing a diverse perspective to the board.
moomoo
5.0
03-30moomoo
HEALTHEQUITY NAMES BILL GASSEN, CEO OF SANFORD HEALTH, TO ITS BOARD OF DIRECTORS
  • Health Equity Appointment: Bill Gassen has been appointed as the CEO of Sanford Health, focusing on health equity initiatives.

  • Board of Directors: Gassen will also serve on the Board of Directors, contributing to strategic decisions and governance.

Yahoo Finance
9.5
03-18Yahoo Finance
HealthEquity Reports Significant Q4 Growth
  • Revenue and Net Income Growth: HealthEquity reported a 7% year-over-year revenue increase to $334.6 million in Q4, with net income soaring 89% to $49.7 million, indicating strong market performance and enhanced profitability.
  • HSA Account Expansion: The company added a record 550,000 Health Savings Accounts (HSAs) in Q4, bringing the total to 17.8 million accounts, reflecting robust growth potential and an expanding customer base in the health savings market.
  • Shareholder Returns and Cash Flow: HealthEquity returned over $300 million to shareholders through its share repurchase program, reducing diluted shares by approximately 3%, while generating $457 million in cash flow from operations, enhancing financial flexibility.
  • Future Outlook and Guidance: The company expects fiscal 2027 revenue to be between $1.405 billion and $1.415 billion, with GAAP net income projected between $239 million and $246 million, demonstrating confidence in future growth and market opportunities.
NASDAQ.COM
2.0
03-18NASDAQ.COM
HealthEquity (HQY) Q4 2026 Earnings Transcript
seekingalpha
9.5
03-17seekingalpha
HealthEquity Q4 Earnings Beat Expectations
  • Earnings Highlights: HealthEquity reported a Q4 non-GAAP EPS of $0.95, beating expectations by $0.05, indicating a sustained enhancement in profitability and reflecting robust performance in the health management sector.
  • Revenue Growth: Q4 revenue reached $334.6 million, up 7.3% year-over-year, exceeding market expectations by $1.78 million, demonstrating strong growth in customer base and service demand.
  • Future Outlook: Management expects revenues for the fiscal year ending January 31, 2027, to be between $1.405 billion and $1.415 billion, slightly below the consensus of $1.41 billion, indicating a cautious approach to future growth.
  • Net Income Projections: The anticipated net income ranges from $239 million to $246 million, resulting in diluted earnings per share of $2.78 to $2.85, reflecting the company's efforts in cost control and enhancing profitability.
NASDAQ.COM
9.5
03-17NASDAQ.COM
Multiple Companies Set to Report Earnings
  • Lululemon Earnings Forecast: Lululemon athletica is expected to report an EPS of $4.77 for the quarter ending January 31, 2026, reflecting a 22.31% decrease year-over-year, indicating increased competitive pressure despite consistently beating expectations over the past year.
  • DocuSign Growth: DocuSign anticipates an EPS of $0.34, representing a 21.43% increase compared to the same quarter last year, and has beaten expectations every quarter in the past year, highlighting its strong growth potential in the internet software sector.
  • HealthEquity Performance: HealthEquity is projected to report an EPS of $0.70, a 27.27% increase year-over-year, and has consistently exceeded expectations in the past year, demonstrating its ongoing growth capability in the medical services industry.
  • NextNav Earnings Outlook: NextNav expects an EPS of -$0.13, showing a 48.00% year-over-year improvement, indicating a trend of recovery in the technology services sector despite still reporting negative earnings.
Wall Street analysts forecast HQY stock price to rise
11 Analyst Rating
Wall Street analysts forecast HQY stock price to rise
9 Buy
1 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
89.00
Averages
117.09
High
129.00
Current: 0.000
sliders
Low
89.00
Averages
117.09
High
129.00
Deutsche Bank
Buy
maintain
$120 -> $128
AI Analysis
2026-03-19
Reason
Deutsche Bank
Price Target
$120 -> $128
AI Analysis
2026-03-19
maintain
Buy
Reason
Deutsche Bank raised the firm's price target on HealthEquity to $128 from $120 and keeps a Buy rating on the shares. The firm says the company's visibility and execution continued in Q4.
Barrington
Outperform
to
NULL
downgrade
$125 -> $110
2026-03-18
Reason
Barrington
Price Target
$125 -> $110
2026-03-18
downgrade
Outperform
to
NULL
Reason
Barrington lowered the firm's price target on HealthEquity to $110 from $125 and keeps an Outperform rating on the shares following the Q4 report. The company topped expectations and raised its fiscal 2027 revenue and adjusted EBITDA guidance, the analyst tells investors in a research note. Barrington believes HealthEquity remains well positioned to benefit from health savings account market expansion.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HQY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Healthequity Inc (HQY.O) is 22.01, compared to its 5-year average forward P/E of 34.01. For a more detailed relative valuation and DCF analysis to assess Healthequity Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
34.01
Current PE
22.01
Overvalued PE
45.50
Undervalued PE
22.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
18.67
Current EV/EBITDA
17.87
Overvalued EV/EBITDA
22.40
Undervalued EV/EBITDA
14.95

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
6.07
Current PS
6.78
Overvalued PS
6.96
Undervalued PS
5.17

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks likely to go up 2% tomorrow morning
Intellectia · 12 candidates
Market Cap: >= 2.00BMoving Average Relationship: PriceAboveMA20One Day Rise Prob: >= 70One Day Predict Return: >= 2.0%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HCC logo
HCC
Warrior Met Coal Inc
4.24B
GD logo
GD
General Dynamics Corp
96.15B
FUTU logo
FUTU
Futu Holdings Ltd
21.38B
HQY logo
HQY
Healthequity Inc
6.71B
FIVE logo
FIVE
Five Below Inc
12.19B
ETOR logo
ETOR
eToro Group Ltd
2.50B
What stock has the most upside this 2026?
Intellectia · 48 candidates
Market Cap: 1000.00M - 100.00BAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 10List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
KSPI logo
KSPI
Kaspi.kz AO
15.02B
QFIN logo
QFIN
Qfin Holdings Inc
2.14B
NICE logo
NICE
Nice Ltd
7.07B
PTC logo
PTC
PTC Inc
19.28B
JD logo
JD
JD.com Inc
42.34B
TW logo
TW
Tradeweb Markets Inc
24.31B
rerun right now to see if the list changes
Intellectia · 29 candidates
Price: $3.00 - $100.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 60One Day Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SIDU logo
SIDU
Sidus Space Inc
234.80M
DBGI logo
DBGI
Digital Brands Group Inc (Pre-Reincorporation)
68.45M
MED logo
MED
Medifast Inc
128.60M
AAP logo
AAP
Advance Auto Parts Inc
2.75B
CMBT logo
CMBT
CMB.TECH NV
3.30B
LSTA logo
LSTA
Lisata Therapeutics Inc
35.81M
show me more stocks like alit
Intellectia · 17 candidates
Market Cap: 3.00B - 12.00BRevenue Ttm: 1000.00M - 4.00BRegion: USWeekly Average Turnover: >= 3,000,000Annual Revenue Yoy Growth: 10.0% - 30.0%
Ticker
Name
Market Cap$
top bottom
BSY logo
BSY
Bentley Systems Inc
11.98B
NTNX logo
NTNX
Nutanix Inc
11.24B
CFLT logo
CFLT
Confluent Inc
10.82B
CART logo
CART
Maplebear Inc
10.24B
MANH logo
MANH
Manhattan Associates Inc
10.01B
PCOR logo
PCOR
Procore Technologies Inc
9.79B

Whales Holding HQY

W
Wasatch Advisors LP
Holding
HQY
+5.12%
3M Return
A
Atalan Capital Partners, LP
Holding
HQY
+5.03%
3M Return
S
Stephens Investment Management Group, LLC
Holding
HQY
+1.86%
3M Return
W
Westfield Capital Management Company, L.P.
Holding
HQY
+0.77%
3M Return
A
Aristotle Capital Boston, LLC
Holding
HQY
+0.52%
3M Return
N
Nationwide Fund Advisors
Holding
HQY
-1.71%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Healthequity Inc (HQY) stock price today?

The current price of HQY is 83.57 USD — it has increased 2.57

What is Healthequity Inc (HQY)'s business?

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.

What is the price predicton of HQY Stock?

Wall Street analysts forecast HQY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HQY is117.09 USD with a low forecast of 89.00 USD and a high forecast of 129.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Healthequity Inc (HQY)'s revenue for the last quarter?

Healthequity Inc revenue for the last quarter amounts to 334.59M USD, increased 7.30

What is Healthequity Inc (HQY)'s earnings per share (EPS) for the last quarter?

Healthequity Inc. EPS for the last quarter amounts to 0.58 USD, increased 93.33

How many employees does Healthequity Inc (HQY). have?

Healthequity Inc (HQY) has 2814 emplpoyees as of April 01 2026.

What is Healthequity Inc (HQY) market cap?

Today HQY has the market capitalization of 7.06B USD.